Company

NextRNA Therapeutics, Inc.

NextRNA Therapeutics develops small-molecule therapies targeting non-coding RNA.

About

Founded in 2019 in Massachusetts, NextRNA Therapeutics develops therapies targeting non-coding RNA for diseases in neurology, oncology, and immunology. Its small molecules aim to limit interactions between non-coding RNA and proteins. The company raised USD 46.8 million in Series A funding in March 2022, co-led by Cobro Ventures and Lightchain Capital, to expand its discovery platform and pipeline.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in